Graft Polymer (UK) PLC
Climate Impact & Sustainability Data (2021, 2022, 2023)
Reporting Period: 2021
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Less than 40,000 kWh/year
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Developed proprietary polymer modification technologies using recycled raw materials and a closed-loop system to reduce waste.
Social Achievements
- Not disclosed
Governance Achievements
- Established an Audit and Risk Committee and a Remuneration Committee post period end.
- Adopted a Group-wide anti-corruption and bribery policy post period end.
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Aim to have the Group operating on a positive cash inflow as of July 2023.
Environmental Challenges
- Limited operations during the period made measuring carbon footprint impractical.
- Covid-19 impacted client orders.
- Early stage of operations with no guarantee of future growth.
- Technological advances could make products obsolete.
- Significant competition from organizations with greater capital resources.
- Dependence on a small number of customers.
- Potential challenges in establishing, protecting, and enforcing intellectual property rights.
- Uncertainty around product adoption and demand.
Mitigation Strategies
- Investing in production and laboratory equipment to support growth and develop new technologies.
- Moving to a two-shift operation to meet demand.
- Securing distribution relationships with multiple partners globally.
- Ongoing R&D program to generate proprietary know-how.
- Implementing an anti-corruption and anti-bribery policy.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: HACCP (GraftBio division)
Third-party Assurance: PKF Littlejohn LLP
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2022
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:160,000 kWh/year
Water Consumption:Not disclosed
Waste Generated:Almost zero tons/year
Carbon Intensity:Not disclosed
ESG Focus Areas
- Environmental Management
- Waste Reduction
Environmental Achievements
- ISO 14001 accreditation granted for Slovenian facility, minimizing waste to almost zero through closed-loop processing.
Social Achievements
- Not disclosed
Governance Achievements
- Established an Audit Committee and a Remuneration Committee.
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Increase revenue significantly in 2023.
Environmental Challenges
- Increased energy consumption due to the start of manufacturing operations.
- Uncertainty associated with future revenue and reliance on market funding.
- Historically reliant on a small number of customers.
Mitigation Strategies
- Regular review of energy consumption and implementation of efficiency optimization strategies.
- Expansion of customer base and securing distribution relationships with multiple global partners.
- Monitoring the impact of inflation on the business by looking closely at gross profit margins and other key financial indicators.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: ISO 14001, HACCP
Third-party Assurance: PKF Littlejohn LLP
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Grafted Fluoropolymers
Awards & Recognition
- Not disclosed
Reporting Period: 2023
Environmental Metrics
Total Energy Consumption:160,000 kwh
ESG Focus Areas
- Energy Consumption
- Waste from Production
- Diversity and Inclusion
Social Achievements
- The Group employs Yifat Steuer as its Chief Financial Officer and therefore meets the requirements for gender diversity in senior management positions.
Governance Achievements
- The Group has adopted, a code for Directors' dealings in securities which is appropriate for a company whose securities are traded on this main market and is in accordance with the requirements of the Market Abuse Regulation which came into effect in 2016.
- The Group has a zero -tolerance approach to bribery and corruption and has recently put an anti -bribery and corruption policy in place to protect the Group, its employees and those third parties to which the business engages with.
Climate Goals & Targets
Short-term Goals:
- Equity fundraise in the near future for working capital purposes and the development of a modified business development strategy.
Environmental Challenges
- Conflicts in the Middle East, Ukraine and the Red Sea significantly disrupted operations and presented substantial challenges to the Board’s ability to manage the future.
- Elevated logistical costs for raw materials imported from China along with cashflow risks.
- General economic turmoil in Europe leading to reduced overall demand.
- Woeful trading conditions for Graft Polymer’s Slovenian manufacturing facility.
- Loss making, recording a financial loss of £3,120,000 for the year ended 31 December 2023
- Forecasted negative cash position in the near future, leading to an increase in liability rather than a profit centre in the Slovenian entity
Mitigation Strategies
- Disposal of the Slovenian entity to a private consortium in Slovenia for nominal consideration.
- Focus on the Graft Bio division.
- Minimise costs and overheads to ensure that the Group remains solvent.
- £200,000 loan facility to support the Group as they prepare a prospectus which will in turn facilitate a larger fundraise.